Back to Search
Start Over
MiR-126: a novel route for natalizumab action?
- Source :
-
Multiple Sclerosis Journal . Sep2014, Vol. 20 Issue 10, p1363-1370. 8p. 1 Chart, 3 Graphs. - Publication Year :
- 2014
-
Abstract
- The article discusses the research on MiR-126 expression in natalizumab-treated relapsing-remitting multiple sclerosis (RRMS) patients. It states that MiR-126 was down-regulated in cells of patients treated with natalizumab and up-regulated during relapse. It notes that MiR-126 expression correlated with POU2AF1 regulator. It mentions that the strong up-regulation of genes appeared to be treatment duration-dependent.
Details
- Language :
- English
- ISSN :
- 13524585
- Volume :
- 20
- Issue :
- 10
- Database :
- Academic Search Index
- Journal :
- Multiple Sclerosis Journal
- Publication Type :
- Academic Journal
- Accession number :
- 97931932
- Full Text :
- https://doi.org/10.1177/1352458514524998